Fidelity Investments’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.3K | Sell |
25,046
-53,188
| -68% | -$84.3K | ﹤0.01% | 4260 |
|
|
2025
Q4 | $108K | Buy |
78,234
+31,201
| +66% | +$65.3K | ﹤0.01% | 3721 |
|
|
2025
Q3 | $128K | Buy |
47,033
+331
| +0.7% | +$1.18K | ﹤0.01% | 3563 |
|
|
2025
Q2 | $163K | Hold |
46,702
| – | – | ﹤0.01% | 3395 |
|
|
2025
Q1 | $172K | Hold |
46,702
| – | – | ﹤0.01% | 3308 |
|
|
2024
Q4 | $75.2K | Hold |
46,702
| – | – | ﹤0.01% | 3667 |
|
|
2024
Q3 | $35.5K | Hold |
46,702
| – | – | ﹤0.01% | 3925 |
|
|
2024
Q2 | $84.1K | Hold |
46,702
| – | – | ﹤0.01% | 3374 |
|
|
2024
Q1 | $222K | Hold |
46,702
| – | – | ﹤0.01% | 2992 |
|
|
2023
Q4 | $135K | Hold |
46,702
| – | – | ﹤0.01% | 3100 |
|
|
2023
Q3 | $63K | Sell |
46,702
-273
| -0.6% | -$478 | ﹤0.01% | 3274 |
|
|
2023
Q2 | $101K | Sell |
46,975
-1,091
| -2% | -$2.65K | ﹤0.01% | 3159 |
|
|
2023
Q1 | $140K | Sell |
48,066
-146
| -0.3% | -$736 | ﹤0.01% | 3090 |
|
|
2022
Q4 | $331K | Sell |
48,212
-168
| -0.3% | -$793 | ﹤0.01% | 2855 |
|
|
2022
Q3 | $154K | Sell |
48,380
-2,243
| -4% | -$8.15K | ﹤0.01% | 3129 |
|
|
2022
Q2 | $163K | Buy |
50,623
+3,237
| +7% | +$9.4K | ﹤0.01% | 3178 |
|
|
2022
Q1 | $144K | Sell |
47,386
-947,961
| -95% | -$3.2M | ﹤0.01% | 3333 |
|
|
2021
Q4 | $4.44M | Sell |
995,347
-164,571
| -14% | -$806K | ﹤0.01% | 2397 |
|
|
2021
Q3 | $7.61M | Sell |
1,159,918
-228
| -0% | -$2.19K | ﹤0.01% | 2230 |
|
|
2021
Q2 | $18.6M | Buy |
1,160,146
+263,444
| +29% | +$3.64M | ﹤0.01% | 1876 |
|
|
2021
Q1 | $11.1M | Buy |
896,702
+616,840
| +220% | +$9.46M | ﹤0.01% | 1998 |
|
|
2020
Q4 | $3.11M | Sell |
279,862
-1,700
| -0.6% | -$12.8K | ﹤0.01% | 2300 |
|
|
2020
Q3 | $1.37M | Buy |
281,562
+234,860
| +503% | +$891K | ﹤0.01% | 2372 |
|
|
2020
Q2 | $90K | Hold |
46,702
| – | – | ﹤0.01% | 2730 |
|
|
2020
Q1 | $88K | Hold |
46,702
| – | – | ﹤0.01% | 2692 |
|
|
2019
Q4 | $210K | Sell |
46,702
-29,290
| -39% | -$182K | ﹤0.01% | 2630 |
|
|
2019
Q3 | $631K | Sell |
75,992
-144,055
| -65% | -$1.57M | ﹤0.01% | 2490 |
|
|
2019
Q2 | $2.75M | Buy |
220,047
+1
| +0% | +$14 | ﹤0.01% | 2250 |
|
|
2019
Q1 | $3.36M | Sell |
220,046
-4,214
| -2% | -$69.7K | ﹤0.01% | 2184 |
|
|
2018
Q4 | $4.34M | Sell |
224,260
-148,477
| -40% | -$3.26M | ﹤0.01% | 2079 |
|
|
2018
Q3 | $11.9M | Sell |
372,737
-9,397
| -2% | -$286K | ﹤0.01% | 1882 |
|
|
2018
Q2 | $10.2M | Buy |
+382,134
| New | +$10.4M | ﹤0.01% | 1937 |
|
Other funds holding STIM
MAM
VCM
LG
FCM
MCM
Fidelity Investments's STIM Position: Q1 2026 in Review
Fidelity Investments reduced its Neuronetics (STIM) stake by 68% in Q1 2026, selling an estimated $84.3K and leaving 25,046 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.
Fidelity Investments first reported a position in STIM in Q2 2018 and has held it in 32 quarters since. The position peaked at $18.6M in Q2 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.
- Fidelity Investments held 25,046 shares of Neuronetics worth $36.3K as of Q1 2026.
- Fidelity Investments sold 53,188 Neuronetics shares in Q1 2026, an estimated $84.3K.
- Neuronetics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4260 holding.
- Fidelity Investments first reported a position in Neuronetics in Q2 2018 and has held it in 32 quarters since.
- Fidelity Investments's Neuronetics position peaked at $18.6M in Q2 2021.
- 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.